Immunic Inc. buy Brookline Capital Management
Start price
05.04.24
/
50%
€1.27
Target price
05.04.25
€9.25
Performance (%)
-9.72%
Price
29.04.24
€1.14
Summary
This prediction is currently active. With a performance of -9.72%, the BUY prediction for Immunic Inc. by Brookline_Capital_Ma is down slightly. This prediction currently runs until 05.04.25. The prediction end date can be changed by Brookline_Capital_Ma at any time. Brookline_Capital_Ma has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Immunic Inc. | -0.609% |
| iShares Core DAX® | 0.961% |
| iShares Nasdaq 100 | 2.626% |
| iShares Nikkei 225® | 0.217% |
| iShares S&P 500 | 1.540% |
Comments by Brookline_Capital_Ma for this prediction
In the thread Immunic Inc. diskutieren
Immunic, Inc. (NASDAQ: IMUX) is now covered by analysts at Brookline Capital Management. They set a "buy" rating and a $10.00 price target on the stock.
Ratings data for IMUX provided by MarketBeat